Correlation Between Visa and ProQR Therapeutics
Can any of the company-specific risk be diversified away by investing in both Visa and ProQR Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Visa and ProQR Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Visa Class A and ProQR Therapeutics BV, you can compare the effects of market volatilities on Visa and ProQR Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Visa with a short position of ProQR Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Visa and ProQR Therapeutics.
Diversification Opportunities for Visa and ProQR Therapeutics
0.72 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Visa and ProQR is 0.72. Overlapping area represents the amount of risk that can be diversified away by holding Visa Class A and ProQR Therapeutics BV in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ProQR Therapeutics and Visa is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Visa Class A are associated (or correlated) with ProQR Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ProQR Therapeutics has no effect on the direction of Visa i.e., Visa and ProQR Therapeutics go up and down completely randomly.
Pair Corralation between Visa and ProQR Therapeutics
Taking into account the 90-day investment horizon Visa is expected to generate 4.07 times less return on investment than ProQR Therapeutics. But when comparing it to its historical volatility, Visa Class A is 7.57 times less risky than ProQR Therapeutics. It trades about 0.1 of its potential returns per unit of risk. ProQR Therapeutics BV is currently generating about 0.05 of returns per unit of risk over similar time horizon. If you would invest 176.00 in ProQR Therapeutics BV on August 31, 2024 and sell it today you would earn a total of 208.00 from holding ProQR Therapeutics BV or generate 118.18% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Visa Class A vs. ProQR Therapeutics BV
Performance |
| Timeline |
| Visa Class A |
| ProQR Therapeutics |
Visa and ProQR Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Visa and ProQR Therapeutics
The main advantage of trading using opposite Visa and ProQR Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Visa position performs unexpectedly, ProQR Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ProQR Therapeutics will offset losses from the drop in ProQR Therapeutics' long position.| Visa vs. American Express | Visa vs. PayPal Holdings | Visa vs. Capital One Financial | Visa vs. Upstart Holdings |
| ProQR Therapeutics vs. Annexon | ProQR Therapeutics vs. Arrowhead Pharmaceuticals | ProQR Therapeutics vs. Day One Biopharmaceuticals | ProQR Therapeutics vs. Terns Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.
Other Complementary Tools
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Bonds Directory Find actively traded corporate debentures issued by US companies |